UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODP
1126
DELISTED
ODP
ODP
| $3.48M | ﹤0.01% |
40,198
+7,481
| +23% | +$688K |
|
1127
Starwood Property Trust
STWD
$5.95B
| $3.47M | ﹤0.01% |
160,804
+20,300
| +14% | +$481K |
|
1128
iShares Russell 1000 Growth ETF
IWF
$127B
| $3.46M | ﹤0.01% |
139,604
-194,776
| -58% | -$4.9M |
|
1129
Hexcel
HXL
$7.87B
| $3.45M | ﹤0.01% |
69,380
+4,900
| +8% | +$247K |
|
1130
Huntsman Corp
HUN
$1.79B
| $3.44M | ﹤0.01% |
155,949
+10,300
| +7% | +$233K |
|
1131
Petrobras Class A
PBR.A
$106B
| $3.44M | ﹤0.01% |
421,681
-73,702
| -15% | -$617K |
|
|
JUNO
1132
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.44M | ﹤0.01% |
64,481
-969
| -1% | -$51.4K |
|
1133
PTC
PTC
$15.2B
| $3.44M | ﹤0.01% |
83,796
+5,800
| +7% | +$229K |
|
1134
Bank of Hawaii
BOH
$3.16B
| $3.43M | ﹤0.01% |
51,381
+18,491
| +56% | +$1.17M |
|
1135
Stantec
STN
$8.33B
| $3.4M | ﹤0.01% |
116,190
-13,644
| -11% | -$374K |
|
|
YDLE
1136
DELISTED
YODLEE INC COMMON STOCK
YDLE
| $3.38M | ﹤0.01% |
234,414
-4,186
| -2% | -$57.8K |
|
1137
Assured Guaranty
AGO
$3.69B
| $3.38M | ﹤0.01% |
140,803
-476,660
| -77% | -$13.3M |
|
|
SNV
1138
DELISTED
Synovus
SNV
| $3.32M | ﹤0.01% |
107,595
+7,700
| +8% | +$223K |
|
1139
Acadia Realty Trust
AKR
$2.95B
| $3.31M | ﹤0.01% |
113,681
+15,993
| +16% | +$504K |
|
|
WOOF
1140
DELISTED
VCA Inc.
WOOF
| $3.29M | ﹤0.01% |
60,470
+6,428
| +12% | +$340K |
|
1141
Cullen/Frost Bankers
CFR
$10.4B
| $3.27M | ﹤0.01% |
41,601
+2,200
| +6% | +$162K |
|
1142
Live Nation Entertainment
LYV
$42.8B
| $3.26M | ﹤0.01% |
118,746
+10,573
| +10% | +$289K |
|
1143
Compass Minerals
CMP
$1.24B
| $3.26M | ﹤0.01% |
39,707
+5,963
| +18% | +$525K |
|
1144
NewMarket
NEU
$8.22B
| $3.25M | ﹤0.01% |
7,319
+519
| +8% | +$239K |
|
1145
Madison Square Garden
MSGS
$9.46B
| $3.24M | ﹤0.01% |
54,462
+3,785
| +7% | +$227K |
|
1146
Lennox International
LII
$15.6B
| $3.24M | ﹤0.01% |
30,044
+1,800
| +6% | +$200K |
|
|
1147
Yelp
YELP
$1.43B
| $3.22M | ﹤0.01% |
74,772
-3,008,452
| -98% | -$140M |
|
|
AWH
1148
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $3.22M | ﹤0.01% |
74,433
-1,490
| -2% | -$63.1K |
|
1149
National Health Investors
NHI
$3.64B
| $3.21M | ﹤0.01% |
51,508
+3,690
| +8% | +$247K |
|
1150
Old Dominion Freight Line
ODFL
$44.5B
| $3.21M | ﹤0.01% |
140,244
+9,000
| +7% | +$214K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.